Noom launches a GLP-1-based, long-term, preventive health care program Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily approved by the FDA for managing type 2 diabetes mellitus and, in some cases, chronic weight management
People with type 2 diabetes , for example, tend to lose weight more slowly on semaglutide and other GLP-1 medications
They also provide steady energy and make smaller meals more satisfying
They work by regulating blood sugar, reducing appetite, and improving metabolic function
Many patients start with the Wolverine protocol for a specific injury and later upgrade to KLOW for broader wellness support